Mohammed Gouda

22PUBLICATIONS
82CO-AUTHORS
Liquid biopsiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 19, 2025
Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131).

Mohamed A Gouda, Filip Janku, Ying Yuan

|Feb 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.

Omar Alhalabi, Mohamed A Gouda, Denái R Milton

|Feb 06, 2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H.

Mohamed A Gouda, Zihan Wei, Jordi Rodon

|Jan 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.

Mohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava

|Jan 16, 2025
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial.

Mohamed A Gouda, Abdulrazzak Zarifa, Yali Yang

|Nov 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

Mohamed A Gouda, Bettzy Stephen, Yanyan Tian

Pageof 4

Frequent Collaborators

9 joint publications

Vivek Subbiah

5 joint publications

Funda Meric-Bernstam

3 joint publications

Filip Janku

3 joint publications

Jordi Rodon